How a Boron-Based Drug Passes Through Bacterial Membranes
Author Information
Author(s): Minozzi Manuela, Lattanzi Gianluca, Benz Roland, Costi Maria P., Venturelli Alberto, Carloni Paolo
Primary Institution: University “Roma Tre”
Hypothesis
The study investigates the permeation mechanism of boronic compounds through bacterial membranes.
Conclusion
The research shows that the neutral form of the boron-based β-lactamase inhibitor BZB can efficiently permeate bacterial membranes, while the negatively charged form cannot.
Supporting Evidence
- BZB passes through the membrane in both charged and neutral forms.
- The neutral form of BZB is responsible for the biological activity.
- A water-filled channel assists the translocation of BZB through the membrane.
Takeaway
This study looks at how a special drug can get through the walls of bacteria. It finds that the drug works better when it's not charged.
Methodology
The study used electrophysiological experiments and molecular dynamics simulations to analyze the permeation of BZB through model membranes.
Limitations
The study primarily focuses on model membranes and may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website